You are here

Article Text

Article menu
Download PDFPDF
Letter
Severe alcohol-related liver disease admissions post-COVID-19 lockdown: canary in the coal mine?
  1. Zillah Cargill1,
  2. Sajith Kattiparambil1,
  3. Navjyot Hansi1,
  4. Ashley Barnabas1,
  5. Debbie L Shawcross1,
  6. Roger Williams2,3,
  7. Kosh Agarwal1
  1. 1 Institute of Liver Studies, King's College Hospital Liver Unit, London, London, UK
  2. 2 Foundation for Liver Research, The Institute of Hepatology London, London, UK
  3. 3 Faculty of Life Sciences & Medicine, King’s College London, London, UK
  1. Correspondence to Dr Zillah Cargill, King's College Hospital Liver Unit, London SE5 9RS, UK; zillah.cargill{at}nhs.net

https://doi.org/10.1136/flgastro-2020-101693

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The COVID-19 pandemic presents significant complexities for adapting health care provision to our chronic liver disease patients. Concerns have been raised that patients with alcohol-use disorders may be severely impacted and vulnerable during ‘lockdown’. Community alcohol and drug services were greatly disrupted during the peak of the COVID-19 pandemic, and provision of support to patients significantly reduced. Staffing of these services was diminished and social distancing measures made provision of detoxification services challenging.

    In England in 2018/2019, there were 1.26 million hospital admissions related to alcohol consumption.1 The continued burden of liver disease from excess alcohol, with increasing numbers of hospital admissions particularly in deprived areas of the UK, has been repeatedly highlighted by the Lancet Commission into liver disease.2 In the initial wave of the COVID-19 pandemic, the Office of National …

    View Full Text